Senators Probe Altria’s Lobbying Amid FDA’s Vaping “Enforcement Discretion” Policy Shift
Senators’ inquiry probes Altria’s lobbying amid FDA’s new enforcement‑discretion vape policy, spotlighting potential market shifts, regulatory gaps, and public‑health impacts.
3 minutes to read









